Developing a Peer Support Model for Depression Care in Patients With Diabetes Mellitus, and Testing it's Efficacy on Patient Outcomes; a Randomized Control Trial Protocal
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Makerere University
- Enrollment
- 130
- Primary Endpoint
- Depression Clinical Remission
Study Overview
Brief Summary
Introduction: The prevalence of Diabetes Mellitus (DM) is on the rise the world over. About 30% of DM patients suffer from Depression. Depression in DM patients is associated with adverse outcomes including poor medication adherence, poor glycaemic control, and early death. In resource constrained sub-Saharan Africa (SSA) clinics where patient volumes are high and staff shortages rife, peer support has been suggested as a means of delivering psychosocial care for persons with chronic illnesses in order to improve patient's outcomes. However, little has been done to examine the efficacy of peer support on clinical outcomes.
Project aims: The main study objective will be developing a peer support model of depression care for patients with DM and testing its efficacy on clinical outcomes.
Methods: This study will employ both qualitative and quantitative measures. First, the investigators will present the peer support model to health workers within the DM clinic, and ask them about the feasibility of using such a model for DM patients with depression. The investigators will then identify 10 DM patients with major depression and initiate them on antidepressants. Once the patients are in clinical remission, the investigators will interview them to assess their perceptions about the feasibility of using peer support for DM patients newly diagnosed with depression. The investigators will also interview health care workers and hospital administrators to assess their perception about using peer support within the clinics, and potential barriers that need to be addressed before implementation of the model.
Based on the data from the qualitative interviews, the investigators will refine and adapt the peer support model, and then train 10 DM patients who have received antidepressants and are in clinical remission to deliver peer support to newly diagnosed patients with depression. Newly diagnosed depressed patients will be randomly assigned to receive either antidepressants plus peer support (n=65) or antidepressants alone (n=65). Study participants will be followed for 48 weeks and assessed for, glycaemic control, depression severity, mental illness stigma, depression treatment uptake and adherence.
Result: the investigators anticipate that the findings about the efficacy of peer support on DM and depression outcomes will be useful in generating data about effect sizes necessary for calculating a sample size for a cluster randomized trial (CRT).
Detailed Description
Methods: This will be a pragmatic randomized control trial with a 1:1 allocation ratio between cases and controls.
Study Setting: This project will be implemented at the DM clinic of Nsambya Hospital in Kampala City. The clinic, which is staffed by three nurses, a medical officer and a specialist physician, is open once a week. The nurses provide most of the DM care including eliciting symptoms, providing medication refills, as well as referring complicated cases to the medical officer (MO) and specialist physician. The medical officer and specialist physician manage referrals and complications of DM.
Identification of depressed patients to participate in a peer support feasibility study: In the first four weeks of the study, all clinic attendees will be screened for depression by a trained lay health care worker(TLHW) using the PHQ-2 at triage. Screen positive cases (PHQ-2≥3) will be sent to the MO who will conduct a depression diagnostic interview using the Mini International Neuropsychiatric Interview (MINI) till 10 depressed patients are identified. All depressed patients will be initiated on either Imipramine 75mg/day or Fluoxetine 20mg/day, and then reassessed at week 4 and week 6 for side effects and symptom remission using the Hamilton Depression Rating scale (HAM-D).
Conducting qualitative interviews to assess feasibility of peer support: When the 10 patients are in remission (˜ 6-8 weeks) the investigators will conduct qualitative interviews with them, hospital administrators (n=2), and medical personel at the DM clinic (n=5). During the interview, the investigators will assess the participant's perceptions about the feasibility and acceptability of engaging experienced DM patients to provide peer support to patients newly diagnosed with depression. Informed consent will be sought from all participants.
Interview procedure: Dr Elialilia Okello will conduct the qualitative interviews. The participants will be asked about whom in the DM clinic would be a suitable candidate to provide peer support to newly diagnosed depressed patients. The peer support model will be presented to participants so that they can internalize/appreciate the concept, Interview guide: The interviews will be based on a guide with detailed standard probes to ensure that key questions are addressed, and to allow comparisons across individuals and categories of respondents. Questions will be open-ended to allow not only the exploration of new leads but also generation of rich narratives. All interviews will be tape recorded, translated in English (in cases where Luganda, the local language is used) and transcribed verbatim.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Masking Description
Random sequence generation will be done by an independent biostatistician
Eligibility Criteria
- Ages
- 18 Years to — (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •All Patients with Diabetes Melitus who have been accessing care at the clinic for atleast 6 months
Exclusion Criteria
- •Patients with overt psychiatric or physical illness for which emergency medical care is needed
Arms & Interventions
Peer Support
Participants in this group will receive peer support as well as antidepressant medications comprised of either Fluoxetine 20mg O.D or Imipramine 75mg nocte.
Intervention: Peer support (Behavioral)
No Peer support
Participants will only receive antidepressant medications comprised of either Fluoxetine 20mg O.D or Imipramine 75mg nocte.
Intervention: Peer support (Behavioral)
Outcomes
Primary Outcomes
Depression Clinical Remission
Time Frame: 48 weeks after initiation into antidepressant treatment
A HAM-D score of \<17
Adequate glycaemic control
Time Frame: 48 weeks after initiation into antidepressant treatment
Adequate glycaemic control will be measured as a HbAIc score of \<7
Secondary Outcomes
No secondary outcomes reported
